<DOC>
	<DOCNO>NCT02127762</DOCNO>
	<brief_summary>By 2020 , estimate 3.7 million Canadians diabetes mellitus , type 2 diabetes ( T2DM ) account 90 % case . Estimates prevalence diabetic peripheral neuropathy among adult T2DM range 26 % 47 % . It increase patient age duration disease high 60 70 % old cohort . Diabetic peripheral neuropathy document study numbness , tingle , pain and/or objective sensory change . Pain early manifestation neuropathy may present symptom diabetes . Even best medication procedure rarely relieve 30 % discomfort chronic painful condition . Diabetic patient continue experience debilitate disable pain . Pain affect ability work , ability participate recreational activity , mood relationship . It well-established interdisciplinary approach key treatment type chronic pain , little research do effectiveness interdisciplinary treatment patient suffer painful diabetic peripheral neuropathy . The investigator evaluate effectiveness interdisciplinary approach combine medical treatment mindfulness-based stress reduction ( MBSR ) reduce disability improve quality life among patient painful diabetic peripheral neuropathy . The investigator also evaluate impact program psychological distress , pain cognition , biomarkers stress glycemic function .</brief_summary>
	<brief_title>The Effect Mindfulness Based Stress Reduction Patients With Painful Diabetic Peripheral Neuropathy</brief_title>
	<detailed_description>The investigator recruit 110 adult painful diabetic peripheral neuropathy . All medical treatment optimize pain medicine specialist randomly assign either 8-week group MBSR program wait-list . All participant complete self-report questionnaire , provide hair sample cortisol measurement blood sample measure glycemic index . We collect outcome data group . Patients randomize MBSR data collect 4 time point : 1 ) medical optimization ; 2 ) medical optimization MBSR group intervention begin , 3 ) 2 week group intervention ; 4 ) 3 month follow completion MBSR . Patients randomize control data collect 6-7 time point depend participant enrol trial : 1 ) medical optimization ; 2 ) medical optimization MBSR group intervention begin ; 3 ) 2 week group intervention ; 4 ) 3 month follow completion MBSR ; 5 ) Re-test control group intervention begin ; 6 ) 2 week control group intervention ; 7 ) 3 month control group intervention . The primary hypothesis patient medically optimize , randomize MBSR 30 % high incidence clinically significant ( ≥1.0 decrease mean BPI interference score ) improvement ( responder ) compare control measure 3 month follow completion MBSR . A significant change define ≥ 1 decrease BPI interference score . A one point change Interference Scale , recommend Initiative Methods , Measurement , Pain Assessment Clinical Trials ( IMMPACT ) group minimally clinically important change . This design control effect time disease fluctuation , regression mean , effect test . In preliminary research , primary goal establish proof concept obtain data need plan comparative trial , control placebo effect . We believe wait-list control study necessary foundation build rigorous program research .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Patient age &gt; 18 year Type 1 Type 2 Diabetes Mellitus ( receive insulin ) HbA1c 6.5 % 9.9 % Diagnosis Diabetic Peripheral Neuropathy ( DPN ) &gt; 1 year Report pain &gt; 6 month Score &gt; 3 Douleur Neuropathique4 Questionnaire VAS complete 5/7 day ; Average VAS score &gt; 4 &lt; 9 ( i.e. , moderate severe pain ) . Ability attend minimum 7 9 MBSR workshop Peripheral vascular disease require revascularization low limb amputation Pregnant lactate Active alcohol drug abuse/dependence Previous MBSR train Comorbidity prevent assessment understanding questionnaire Inability speak English French</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Pain</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Glycemic Control</keyword>
	<keyword>diabetic neuropathy</keyword>
	<keyword>mindfulness</keyword>
	<keyword>stress reduction</keyword>
	<keyword>adult</keyword>
	<keyword>chronic pain</keyword>
	<keyword>depression</keyword>
	<keyword>cortisol</keyword>
</DOC>